Abstract:Abstract Introduction The assessment of ex vivo biodistribution is the preferred method for quantification of radiotracers biodistribution in preclinical models, but is not in line with current ethics on animal research. PET imaging allows for noninvasive longitudinal evaluation of tracer distribution in the same animals, but systemic comparison with ex vivo biodistribution is lacking. Our aim was to evaluate the potential of preclinical PET imaging for accurate tracer quantification, especially in tumor models. Methods NEMA NU 4-2008 phantoms were filled with 11 C, 68 Ga, 18 F, or 89 Zr solutions and scanned in Mediso nanoPET/CT and PET/MR scanners until decay. N87 tumor-bearing mice were i.v. injected with either [ 18 F]FDG (~ 14 MBq), kept 50 min under anesthesia followed by imaging for 20 min, or with [ 89 Zr]Zr-DFO-NCS-trastuzumab (~ 5 MBq) and imaged 3 days post-injection for 45 min. After PET acquisition, animals were killed and organs of interest were collected and measured in a γ -counter to determine tracer uptake levels. PET data were reconstructed using TeraTomo reconstruction algorithm with attenuation and scatter correction and regions of interest were drawn using Vivoquant software. PET imaging and ex vivo biodistribution were compared using Bland–Altman plots. Results In phantoms, the highest recovery coefficient, thus the smallest partial volume effect, was obtained with 18 F for both PET/CT and PET/MR. Recovery was slightly lower for 11 C and 89 Zr, while the lowest recovery was obtained with 68 Ga in both scanners. In vivo, tumor uptake of the 18 F- or 89 Zr-labeled tracer proved to be similar irrespective whether quantified by either PET/CT and PET/MR or ex vivo biodistribution with average PET/ex vivo ratios of 0.8–0.9 and a deviation of 10% or less. Both methods appeared less congruent in the quantification of tracer uptake in healthy organs such as brain, kidney, and liver, and depended on the organ evaluated and the radionuclide used. Conclusions Our study suggests that PET quantification of 18 F- and 89 Zr-labeled tracers is reliable for the evaluation of tumor uptake in preclinical models and a valuable alternative technique for ex vivo biodistribution. However, PET and ex vivo quantification require fully described experimental and analytical procedures for reliability and reproducibility.

Meridians Imaging of 18F-FDG and 18F-NaF Tracers Using MicroPET in Rats

Magnetic resonance imaging and acupuncture: a feasibility study on the migration of tracers after injection at acupoints of small animals

Methodological Progress of 18 F-labeled Aromatic PET Radiotracers

Demonstration of in-vivo simultaneous 3D imaging with 18F-FDG and Na131I using Compton–PET system

Clinical Explorations of [ 68 Ga] Ga-FAPI-04 and [ 18 F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging

Evaluation of [18F]tetrafluoroborate as a Potential PET Imaging Agent in a Sodium Iodide Symporter-Transfected Cell Line A549 and Endogenous NIS-Expressing Cell Lines MKN45 and K1

Clinical Explorations of [68ga] Ga-FAPI-04 and [18F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging

18F- flunoroacetate: can it be an alternation for detection of pancereatic cancer using PET/CT ?

Properties of [18F]FAPI monitoring of acute radiation pneumonia versus [18F]FDG in mouse models

Comparison of Intraperitoneal Injection and Intravenous Injection of 18F-FDG PET/CT Imaging in SD Rats

[18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species

The diagnostic value of Na~(18)F PET/CT imaging in bone metastasis

Preliminary Evaluation of 18F-Labeled Benzylguanidine Analogs as NET Tracers for Myocardial Infarction Diagnosis

Dynamic PET/CT Imaging of 68Ga-FAPI-04 in Chinese Subjects

Comparison of 18F PET and 99mtc SPECT Imaging in Phantoms and in Tumored Mice.

Automated Synthesis and Preliminary Evaluation of [ 18 F]FDPA for Cardiac Inflammation Imaging in Rats after Myocardial Infarction

[F-18]Tz14134, A Promising S1pr1/3 Pet Tracer for Imaging Vascular Injury

Dynamic Evaluation the Uptake of 18F-FDG in SD Rats by PET/CT

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice

Automated synthesis and preliminary evaluation of [18F]FDPA for cardiac inflammation imaging in rats after myocardial infarction

Initial Studies of PET-SPECT Dual-Tracer Imaging